Clinical trial
Zinc Supplementation in Shigella Patients
NCT00321126 · International Centre for Diarrhoeal Disease Research, Bangladesh, Other · Completed
Key facts
| NCT number | NCT00321126 |
|---|---|
| Title | Zinc Supplementation in Shigella Patients |
| Official title | Effect of Zinc Supplementation on the Immune and Inflammatory Responses of Children to Shigella Flexneri Infection, and Correlation With Clinical Severity of Illness and Growth Following recoveryEffect of Zinc Supplementation on the Immune and Inflammatory Responses of Children to Shigella Flexneri… |
| Lead sponsor | International Centre for Diarrhoeal Disease Research, Bangladesh, Other |
| Collaborators | Karolinska Institutet |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Testing Effect of Intervention |
| Intervention type | Drug |
| Interventions | Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks. |
| Enrollment | 56 |
| Start date | Jan 1, 1999 |
| Completion | Apr 1, 2002 |
| First posted | May 3, 2006 |
| Last update posted | May 3, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: